mifepristone has been researched along with dinoprostone in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (18.02) | 18.7374 |
1990's | 55 (49.55) | 18.2507 |
2000's | 26 (23.42) | 29.6817 |
2010's | 10 (9.01) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Aguillaume, CJ; Baulieu, EE; Chemama, L; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
Tulandi, T | 1 |
Farnworth, P; Michel, U | 1 |
Burgess, KM; Jenkin, G; Ralph, MM; Thorburn, GD | 1 |
Debu, E; Dufour, B; Fontan, JE; Majorel, P; Scheller, E; Weber, B | 1 |
Croxtall, JD; Flower, RJ | 1 |
Bernadet, P; Boudjemaa, B; Carrie, D; Delay, M; Genestal, M; Livarek, B | 1 |
Arkaravichien, W; Kendle, KE | 1 |
Diochin, P; Frydman, R; Pons, JC; Rais, S | 1 |
Bautrant, E; Blanc, B; Boubli, L; D'Ercole, C; Eyraud, B; Nadal, F | 1 |
Alj, AE; Bienkiewicz, A; Cabrol, D; Carbonne, B; Cedard, L; Dallot, E | 1 |
Baird, DT; Glasier, AF; Kelly, RW; McNeilly, AS; Norman, JE; Wu, WX | 1 |
Bygdeman, M; Gottlieb, C | 1 |
Fontan, JE; Weber, B | 1 |
Elger, W; Stiemer, B | 1 |
Ferguson, J; Hill, NC; López Bernal, A; Mackenzie, IZ; Selinger, M | 1 |
Ferguson, J; Hill, NC; López Bernal, A; MacKenzie, IZ | 1 |
Templeton, AA; Urquhart, DR | 2 |
Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
Haspels, AA; Vervest, HA | 1 |
Angeli, A; Carignola, R; Cavallo, R; del Ponte, D; Gatti, G; Masera, R; Salvadori, A; Sartori, ML | 1 |
Buckshee, K; Hingorani, V; Kumar, S; Malhotra, U; Saraya, L; Sunesh, K | 1 |
Martel, D; Monier, MN; Psychoyos, A; Roche, D | 1 |
Maria, B; Stampf, F | 2 |
Dubois, C; Ulmann, A | 1 |
Bygdeman, M; Swahn, ML | 3 |
Bahzad, C; Belsey, EM; Kovacs, L; Prasad, RN; Saraya, L; Shi, YE; Swahn, ML; Van Look, PF; Wyssling, H | 1 |
Bahzad, C; Templeton, AA; Urquhart, DR | 1 |
Billardon, C; Bure, J; Errasfa, M; Fradin, A; Junien, JL; Rothhut, B; Russo-Marie, F | 1 |
Ardaillou, R; Baud, L; Perez, J | 1 |
Olson, DM; Potestio, FA; Zakar, T | 1 |
Baird, DT; Cameron, IT; Cameron, MJ; Healy, DL; Kelly, RW | 1 |
Kelly, RW; Smith, SK | 1 |
Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Qing, SS | 1 |
Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Hasan, SH; Henderson, D; Neef, G; Rohde, R | 1 |
Fougeyrollas, B; Spira, A; Thonneau, P | 1 |
Brennand, JE; Calder, AA; Greer, IA; Kelly, RW; Leask, R | 1 |
Fougeyrollas, B; Goepp, A; Hercberg, S; Maria, B; Meyer, L; Poirel, H; Spira, A; Thonneau, P | 1 |
Winikoff, B | 1 |
Asribekova, MK; Astakhova, TM; Goncharova, VN; Karpova, SK; Morozova, MS; Murashko, LE; Zaĭtseva, TS | 1 |
Bokström, H; Norström, A; Wiqvist, N | 1 |
Cook, MJ; Haluska, GJ; Kaler, CA; Novy, MJ | 1 |
Hirst, JJ; Mijovic, JE; Olson, DM; Zakar, T | 1 |
Bygdeman, M; Gemzell-Danielsson, K; Gottlieb, C; Swahn, ML | 1 |
Silvestre, L; Ulmann, A | 1 |
Cech, AC; Daly, JM; Gallagher, H; Shou, J | 1 |
Daffos, F; Hohlfeld, P; Jacquemard, F; Menez, D; Mirlesse, V; Werner, H | 1 |
Forcelledo, ML; Poyser, NL | 1 |
Bokström, H; Norström, A; Rdestad, A | 1 |
Guo, F; Hirst, JJ; MacLeod, EA; Olson, DM; Teixeira, FJ; Zakar, T | 1 |
Courtieu, C; Déchaud, H; Marès, P; Marsollier, C; Tailland, ML | 1 |
Carey, F; Horan, MA; Rothwell, NJ; Strijbos, PJ | 1 |
Baird, DT; Cheng, L; Hume, R; Kelly, RW; Thong, KJ | 1 |
Baird, DT | 1 |
Amir, I; Shohami, E; Weidenfeld, J | 1 |
Ho, PC; Ma, HK | 1 |
Baton, C; Benifla, JL; Bourget, P; Bourrier, MC; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
Elstein, M; Macrow, P | 1 |
Cao, HJ; Evans, CH; Frobert, Y; Rezanka, LJ; Sciaky, D; Smith, TJ; Wang, HS; Winn, VD; Young, DA | 1 |
Chrousos, GP; Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C; Zoumakis, E | 1 |
Conaway, HH; Grigorie, D; Lerner, UH | 1 |
Branch, DW; Dudley, DJ; Edwin, SS; Mitchell, MD | 1 |
Fang, X; Mitchell, BF; Wong, S | 1 |
Koide, SS; Li, XJ; Yu, H | 1 |
Beyer, C; González-Flores, O; González-Mariscal, G | 1 |
Milliez, J | 1 |
Ghosh, D; Nayak, NR; Sengupta, J | 1 |
Barnes, PJ; Bergmann, M; Kuitert, LM; Newton, R; Seybold, J | 1 |
Challis, JR; Chwalisz, K; Clifton, VL; Patel, FA | 1 |
Byström, BE; Ekman, GE; Eriksson, HA; Sahlin, L; Stenlund, PM; Stjernholm, YM | 1 |
Aedo, AR; Bygdeman, M; Ekman, G; Stenlund, PM | 1 |
Adamson, L; Bocking, AD; Challis, JR; Fraser, M; Lye, SJ; McKeown, KJ; Riggs, KW; Rurak, D; Small, C | 1 |
Ekman, G; Eriksson, H; Holmgren, A; Lundberg, M; Sahlin, L; Stjernholm, Y; Wang, H | 1 |
Goppelt-Struebe, M; Lanz, S; Ramer, R; Schaefer, D; Schneider, N | 1 |
Bridges, PJ; Ching, L; Kim, L; LeaMaster, BR; Vincent, DL; Weems, CW; Weems, YS | 1 |
He, P; Sun, K; Yang, K | 1 |
Blumenfeld, B; Shakhar, G | 1 |
Tenore, JL | 1 |
Lewis, AW; Randel, RD; Weems, CW; Weems, YS | 1 |
Leonard, B; Phillips, AG; Song, C | 1 |
Tinelli, A; Tinelli, FG; Tinelli, R | 1 |
Friedman, H; Klein, TW; Lu, T; Nazian, SJ; Newton, CA; Perkins, I | 1 |
Bruinse, HW; Christiaens, GC; De Heus, R; Graziosi, GC; Mol, BW | 1 |
de Lapasse, C; Gallot, D; Houlle, C; Laurichesse-Delmas, H; Lémery, D; Sapin, V; Saulnier, JP; Ughetto, S; Vanlieferinghen, P; Vendittelli, F | 1 |
Willems, FE | 1 |
Barnes, PJ; Cambridge, LM; Catley, MC; Chivers, JE; Donnelly, LE; Mak, JC; Newton, R | 1 |
Hirst, JJ; Olson, DM; Palliser, HK; Parkington, HC; Peri, KG; Young, IR | 1 |
Choudhary, N; Gopalan, S; Saha, SC | 1 |
Kadotomi, Y; Kang, Z; Li, X; Song, C | 1 |
Gemzell-Danielsson, K; Lalitkumar, PG; Ståbi, B; Stavreus-Evers, A; Wånggren, K | 1 |
Borg, LA; Sandberg, M | 1 |
Chan, TF; Chen, YH; Chuang, CY; Hsu, SC; Lee, JN; Tsai, EM | 1 |
Falkay, G; Gálik, M; Gáspár, R; Kolarovszki-Sipiczki, Z | 1 |
Alessandri-Haber, N; Bogen, O; Brown, AS; Burkham, J; Dina, OA; Green, PG; Khasar, SG; Levine, JD; Reichling, DB | 1 |
Jansen, NE; Pasker-De Jong, PC; Zondervan, HA | 1 |
Brockman, DE; Grigsby, PL; Hinton, AC; Hinton, RB; Ittenbach, RF; Myatt, L; Pitzer, BA | 1 |
Creemers, JW; Ebbers, S; Lotgering, FK | 1 |
Guo, C; Li, W; Ni, X; Sun, K; Zhu, P; Zhu, X | 1 |
Hayes, JL; Kapp, N; Lohr, PA; Ngo, TD | 1 |
Castro, FM; de Mello, SB; Guzzo, ML; Saad Rached, IC | 1 |
Behar, J; Biancani, P; Xiao, ZL | 1 |
Kawaminami, M; Kurusu, S; Mori, D; Ogino, N; Yonezawa, T | 1 |
Bao, Y; Chen, Y; Fang, P; Li, X; Qiao, Z | 1 |
Hong, H; Jang, BC | 1 |
Akin, JW; Brännström, M; Choi, Y; Curry, TE; Jo, M; Rosewell, KL | 1 |
Dhiman, B; Jamwal, A; Jindal, N; Kandoria, M; Rao, R | 1 |
7 review(s) available for mifepristone and dinoprostone
Article | Year |
---|---|
Nonsurgical treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Chorionic Gonadotropin; Danazol; Dinoprostone; Drug Therapy, Combination; Female; Glucose; Humans; Injections, Intralesional; Injections, Intramuscular; Laparoscopy; Methotrexate; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Vagina | 1992 |
The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Cervix Uteri; Clinical Trials as Topic; Dinoprostone; Drug Synergism; Female; Humans; Laminaria; Mifepristone; Misoprostol; Multicenter Studies as Topic; Myometrium; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Randomized Controlled Trials as Topic; Uterine Contraction | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
[Cervical ripening].
Topics: Cervix Uteri; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics | 1997 |
Methods for cervical ripening and induction of labor.
Topics: Cervical Ripening; Cervix Uteri; Dinoprostone; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Randomized Controlled Trials as Topic; Uterine Contraction | 2003 |
[Induction of labour: which method to use?].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adrenal Cortex Hormones; Alprostadil; Catheterization; Dinoprostone; Estrogens; Female; Humans; Interleukin-8; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Relaxin | 2003 |
Cervical preparation for first trimester surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Cervical Ripening; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2010 |
20 trial(s) available for mifepristone and dinoprostone
Article | Year |
---|---|
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dinoprostone; Drug Evaluation; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1992 |
[Voluntary abortion induced by mifepristone-sulprostone combination. Effect of phloroglucinol on the time required for expulsion in multipara women].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Phloroglucinol; Pregnancy; Uterine Contraction | 1992 |
[RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Cervix Uteri; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 1992 |
[Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premedication | 1992 |
Acetaminophen as a pain enhancer during voluntary interruption of pregnancy with mifepristone and sulprostone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Dinoprostone; Double-Blind Method; Drug Interactions; Female; Humans; Male; Mifepristone; Pain; Pregnancy | 1990 |
The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester.
Topics: Abortion, Induced; Adult; Dinoprost; Dinoprostone; Double-Blind Method; Ergonovine; Female; Humans; Mifepristone; Oxytocin; Pregnancy; Pregnancy Trimester, Second; Randomized Controlled Trials as Topic; Uterine Contraction | 1990 |
The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination.
Topics: Abortion, Induced; Administration, Oral; Adult; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy | 1990 |
An antiprogestin steroid and PGE2 for an early pregnancy termination.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Dinoprostone; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Pregnancy; Progesterone | 1989 |
Clinical trials with RU 486 (mifepristone): an update.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Clinical Trials as Topic; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1989 |
Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Multicenter Studies as Topic; Progestins; Random Allocation | 1989 |
A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Combinations; Female; Hemoglobins; Humans; Metrorrhagia; Mifepristone; Multivariate Analysis; Pregnancy; Suction; Vacuum | 1995 |
RU486: the French experience.
Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
Cervical smooth muscle contractile activity after treatment with mifepristone and progesterone.
Topics: Abortion, Induced; Adult; Cervix Uteri; Dilatation and Curettage; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone | 1994 |
Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Intramuscular; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors | 1993 |
[The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)].
Topics: Adult; Apgar Score; Cervix Uteri; Cesarean Section; Dinoprostone; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Labor, Induced; Mifepristone; Oxytocics; Oxytocin; Placebos; Pregnancy; Pregnancy Outcome; Prospective Studies; Uterine Contraction | 1993 |
Induction of labor with mifepristone--a randomized, double-blind study versus placebo.
Topics: Adult; Apgar Score; Cervical Ripening; Dinoprostone; Double-Blind Method; Female; Fetal Blood; Hormone Antagonists; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Labor, Induced; Mifepristone; Odds Ratio; Pregnancy; Pregnancy Outcome; Prospective Studies; Time Factors; Treatment Outcome | 1999 |
Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment.
Topics: Adult; Dinoprost; Dinoprostone; Embryo Implantation; Fallopian Tubes; Female; Hormone Antagonists; Humans; Immunohistochemistry; Mifepristone; Muscle Contraction; Muscle, Smooth; Progesterone; Receptors, Prostaglandin; Receptors, Prostaglandin E; RNA, Messenger | 2006 |
Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Polymers; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2008 |
Safety and efficacy of mifepristone versus dinoprostone gel in induction of labor: A randomized controlled trial.
Topics: Adult; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Oxytocics; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2019 |
85 other study(ies) available for mifepristone and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Follistatin steady state messenger ribonucleic acid levels in confluent cultures of a rat renal mesangial cell line are regulated by multiple factors.
Topics: Activins; Amino Acid Isomerases; Androstanols; Angiotensin II; Animals; Base Sequence; Carrier Proteins; Cell Line; Cells, Cultured; Cyclosporins; Dihydrotestosterone; Dinoprostone; Epidermal Growth Factor; Estradiol; Fibroblast Growth Factor 2; Follistatin; Gene Expression; Glomerular Mesangium; Glycoproteins; Inhibins; Mifepristone; Molecular Sequence Data; Oligodeoxyribonucleotides; Peptidylprolyl Isomerase; Progesterone; Rats; RNA; RNA Probes; RNA, Messenger; Somatostatin; Tretinoin | 1992 |
Effect of the antiprogestin RU486 on uterine sensitivity to oxytocin in ewes in late pregnancy.
Topics: Animals; Dinoprost; Dinoprostone; Electromyography; Female; Gestational Age; Mifepristone; Oxytocin; Pregnancy; Pregnancy, Animal; Progestins; Sheep; Stimulation, Chemical; Uterus | 1992 |
Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Aldosterone; Annexins; Antibodies, Monoclonal; Calcium-Binding Proteins; Cell Division; Cell Membrane; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Indomethacin; Kinetics; Lung Neoplasms; Mifepristone; Naproxen; Phospholipases; Progesterone; Recombinant Proteins | 1992 |
[Cardiocirculatory arrest after administration of combined mifepristone (Mifegyne) and sulprostone (Nalador) for induced abortion. Possible role of coronary vasospasm].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Coronary Vasospasm; Dinoprostone; Drug Combinations; Electric Countershock; Electrocardiography; Female; Heart; Heart Arrest; Humans; Mifepristone; Pregnancy; Radionuclide Imaging; Risk Factors; Thallium Radioisotopes; Ventricular Fibrillation | 1992 |
Uterine contractile activity in rats induced by mifepristone (RU 486) in relation to changes in concentrations of prostaglandins E-2 and F-2 alpha.
Topics: Animals; Dinoprost; Dinoprostone; Female; Mifepristone; Pregnancy; Rats; Rats, Inbred Strains; Time Factors; Uterine Contraction | 1992 |
Induction of labor and cervical maturation using mifepristone (RU 486) in the late pregnant rat. Influence of a cyclooxygenase inhibitor (Diclofenac).
Topics: Animals; Arachidonic Acids; Cervix Uteri; Diclofenac; Dinoprostone; Electrophoresis, Cellulose Acetate; Female; Glycosaminoglycans; Labor, Induced; Leukotriene B4; Mifepristone; Pregnancy; Radioimmunoassay; Rats; Rats, Inbred Strains | 1991 |
Effects of mifepristone in vivo on decidual prostaglandin synthesis and metabolism.
Topics: Culture Techniques; Decidua; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins; Radioimmunoassay | 1991 |
The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1991 |
Cervical ripening of the rat in dependence on endocrine milieu; effects of antigestagens.
Topics: Animals; Body Water; Cervix Uteri; Dilatation; Dinoprostone; Estradiol; Female; Microscopy, Electron, Scanning; Mifepristone; Organ Size; Progesterone; Progestins; Rats; Rats, Inbred WKY; Tensile Strength | 1990 |
The use of mifepristone prior to prostaglandin-induced mid-trimester abortion.
Topics: Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pressure; Uterus | 1990 |
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1990 |
Preliminary results with the antiprogestational compound RU-486 (mifepristone) for interruption of early pregnancy.
Topics: Abortion, Induced; Binding, Competitive; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dinoprostone; Estradiol; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Progesterone; Prostaglandins E, Synthetic; Receptors, Glucocorticoid; Receptors, Progesterone | 1985 |
Inhibition by cortisol of human natural killer (NK) cell activity.
Topics: 1-Methyl-3-isobutylxanthine; Antibodies, Monoclonal; Cortodoxone; Dinoprostone; Dose-Response Relationship, Drug; Estrenes; Humans; Hydrocortisone; Immunity, Innate; Immunosuppression Therapy; In Vitro Techniques; Interferon-gamma; Killer Cells, Natural; Mifepristone; Progesterone; Prostaglandins E; Receptors, Glucocorticoid; Transcortin | 1987 |
Effect of mifepristone (RU 486) on concentrations of prostaglandin E-2 binding sites in the rat endometrium.
Topics: Animals; Dinoprostone; Endometrium; Estrenes; Female; Mifepristone; Ovariectomy; Progesterone; Progestins; Pseudopregnancy; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Prostaglandin E | 1989 |
Termination of early pregnancy using mifepristone in combination with prostaglandin analogs.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1989 |
Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Dinoprostone; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Prognosis; Ultrasonography | 1989 |
Mifepristone (RU 486) and second-trimester termination.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prostaglandins E | 1987 |
Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Legal; Adult; Dinoprostone; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins | 1989 |
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids.
Topics: Abortifacient Agents, Steroidal; Annexins; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Embryo, Mammalian; Estrenes; Female; Fibroblasts; Glycoproteins; Humans; Kinetics; Mifepristone; Pregnancy; Prostaglandins E; Skin; Tritium | 1985 |
[Termination of pregnancy with a mifepristone-sulprostone combination].
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1987 |
Dexamethasone and hydrogen peroxide production by mesangial cells during phagocytosis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Estrenes; Hydrogen Peroxide; Kidney Glomerulus; Mifepristone; Phagocytosis; Prostaglandins E; Rats; Zymosan | 1986 |
Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism.
Topics: Amnion; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cells, Cultured; Chorion; Dexamethasone; Dinoprostone; Estrenes; Female; Glucocorticoids; Humans; Mifepristone; Pregnancy; Receptors, Glucocorticoid | 1988 |
The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
Topics: Abortion, Therapeutic; Adult; Dinoprostone; Drug Synergism; Estrenes; Female; Humans; Mifepristone; Myometrium; Oxytocin; Pregnancy; Progestins; Prostaglandins E, Synthetic; Time Factors; Uterine Contraction | 1988 |
The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells.
Topics: Dinoprost; Dinoprostone; Endometrium; Estrenes; Fatty Acids; Female; Humans; In Vitro Techniques; Mifepristone; Progesterone; Prostaglandins; Prostaglandins E; Prostaglandins F | 1986 |
The effect of the antiprogestins RU 486 and ZK 98734 on the synthesis and metabolism of prostaglandins F2 alpha and E2 in separated cells from early human decidua.
Topics: Cells, Cultured; Decidua; Dinoprost; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Progestins; Prostaglandins E; Prostaglandins F | 1987 |
Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
Topics: Abortion, Induced; Animals; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Gonanes; Guinea Pigs; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Prostaglandins E, Synthetic; Prostaglandins F; Uterine Contraction | 1987 |
Studies on the mechanisms of action of progesterone antagonists.
Topics: Abortifacient Agents, Steroidal; Animals; Dinoprostone; Embryo Implantation; Epoprostenol; Estrenes; Female; Guinea Pigs; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone; Prostaglandins E, Synthetic; Uterine Contraction | 1986 |
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Receptors, Progesterone; Uterine Contraction | 1985 |
Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dinoprostone; Female; France; Humans; Mifepristone; Peptide Fragments; Pregnancy; Regression Analysis; Retrospective Studies; Time Factors | 1994 |
Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone.
Topics: Amnion; Analysis of Variance; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Chorion; Culture Techniques; Dexamethasone; Dinoprost; Dinoprostone; Female; Hormone Antagonists; Humans; Indomethacin; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Radioimmunoassay; Tetradecanoylphorbol Acetate | 1995 |
"RU 486": a luncheon speech.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Contraception Behavior; Dinoprostone; Drug Industry; Female; Humans; Mifepristone; Politics; Pregnancy; United States | 1994 |
[Sex hormone receptors, prostaglandins and cAMP, in functional activity of the uterus].
Topics: Abortion, Induced; Abortion, Spontaneous; Cyclic AMP; Decidua; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 1994 |
Cervical mucus concentration of prostaglandins E2 and F2 alpha after pretreatment with mifepristone in the first trimester of pregnancy.
Topics: Abortion, Legal; Adult; Cervix Mucus; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Dilatation and Curettage; Dinoprost; Dinoprostone; Female; Gestational Age; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First; Time Factors; Vaginosis, Bacterial | 1995 |
Prostaglandin production during spontaneous labor and after treatment with RU486 in pregnant rhesus macaques.
Topics: Amnion; Animals; Chorion; Decidua; Dinoprost; Dinoprostone; Female; Kinetics; Labor, Obstetric; Macaca mulatta; Mifepristone; Myometrium; Pregnancy; Prostaglandins | 1994 |
Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells.
Topics: Amnion; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Drug Synergism; Female; Gene Expression; Humans; Mifepristone; Pregnancy; Prostaglandin-Endoperoxide Synthases; Ribonucleases; RNA Probes; RNA, Messenger | 1995 |
Glucocorticoid receptor blockade reverses postinjury macrophage suppression.
Topics: Administration, Oral; Animals; Dinoprostone; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Femoral Fractures; Interleukin-6; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred Strains; Mifepristone; Premedication; Random Allocation; Receptors, Glucocorticoid; Stress, Physiological; Superoxides; Tumor Necrosis Factor-alpha | 1994 |
A comparison of the pregnancy-terminating potencies of three anti-progestins in guinea-pigs, and the effects of sulprostone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Synergism; Estrenes; Female; Guinea Pigs; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progestins | 1994 |
Regulation of prostaglandin endoperoxide H synthase by glucocorticoids and activators of protein kinase C in the human amnion.
Topics: Amnion; Culture Techniques; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Glucocorticoids; Humans; Hydrocortisone; Mifepristone; Prostaglandin-Endoperoxide Synthases; Protein Kinase C; Tetradecanoylphorbol Acetate | 1994 |
[The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Cicatrix; Contraindications; Dinoprostone; Drug Tolerance; Female; France; Gestational Age; Humans; Hydatidiform Mole; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Mifepristone; Misoprostol; Polyhydramnios; Pregnancy; Retrospective Studies; Time Factors; Uterine Diseases; Uterine Neoplasms | 1993 |
Impaired febrile responses of aging mice are mediated by endogenous lipocortin-1 (annexin-1).
Topics: Aging; Animals; Annexin A1; Body Temperature; Corticosterone; Dinoprostone; Female; Fever; Immune Sera; Immunoglobulin G; Interleukin-1; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mifepristone; Norepinephrine; Osmolar Concentration; Oxygen Consumption | 1993 |
The effect of mifepristone (RU486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy.
Topics: Chorionic Villi; Cytoplasm; Decidua; Dinoprostone; Endothelium, Vascular; Epithelium; Female; Humans; Immunohistochemistry; Kinetics; Mifepristone; Pregnancy; Prostaglandins E; Trophoblasts | 1993 |
Clinical use of mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Role of glucocorticoids in the regulation of brain prostaglandin biosynthesis under basal conditions and in response to endotoxin.
Topics: Adrenalectomy; Animals; Cerebral Cortex; Cerebral Ventricles; Dexamethasone; Dinoprostone; In Vitro Techniques; Injections, Intraventricular; Lipopolysaccharides; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Reference Values; Spironolactone | 1993 |
Managing miscarriage medically.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation.
Topics: Blotting, Northern; Blotting, Western; Cyclic AMP; Cycloheximide; Dexamethasone; Dinoprostone; Electrophoresis, Gel, Two-Dimensional; Enzyme Induction; Fibroblasts; Humans; Lymphokines; Microscopy, Phase-Contrast; Mifepristone; Orbit; Prostaglandin-Endoperoxide Synthases; Pyrazoles; RNA, Messenger; Transcription, Genetic; Up-Regulation | 1996 |
Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells.
Topics: Adenocarcinoma; Corticotropin-Releasing Hormone; Cyclic AMP; Dexamethasone; Dinoprostone; Endometrial Neoplasms; Endometrium; Epidermal Growth Factor; Estradiol; Female; Gene Expression Regulation; Humans; Indomethacin; Luciferases; Mifepristone; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1996 |
Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
Topics: Acetazolamide; Acetylglucosaminidase; Animals; Animals, Newborn; Anti-Inflammatory Agents; Bone Resorption; Calcitonin; Calcium; Dexamethasone; Dinoprostone; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Hormone Antagonists; Hydrocortisone; Hydroxyurea; Lysosomes; Mice; Mifepristone; Mitomycin; Parathyroid Hormone; Parietal Bone; Phosphates; Progesterone; Proline | 1996 |
Induction of preterm birth in mice by RU486.
Topics: Abortifacient Agents, Steroidal; Animals; Dinoprost; Dinoprostone; Female; Interleukin-6; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mifepristone; Obstetric Labor, Premature; Pregnancy | 1996 |
Effects of RU486 on estrogen, progesterone, oxytocin, and their receptors in the rat uterus during late gestation.
Topics: Animals; Dinoprost; Dinoprostone; Estradiol; Estrogens; Female; Hormone Antagonists; Labor, Obstetric; Mifepristone; Oxytocin; Pregnancy; Pregnancy, Animal; Progesterone; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; Receptors, Progesterone; RNA, Messenger; Uterus | 1997 |
Effect of mifepristone and antiestrogens on uterine PGF2 alpha and PGE2 concentrations in ovariectomized and pregnant rats.
Topics: Abortifacient Agents, Steroidal; Animals; Contraceptives, Postcoital, Synthetic; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Mifepristone; Norandrostanes; Organ Size; Ovariectomy; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
Progesterone receptor participates in the stimulatory effect of LHRH, prostaglandin E2, and cyclic AMP on lordosis and proceptive behaviours in rats.
Topics: Animals; Bucladesine; Cyclic AMP; Dinoprostone; Estradiol; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Mifepristone; Ovariectomy; Posture; Progesterone; Rats; Rats, Wistar; Receptors, Progesterone; Sexual Behavior, Animal | 1997 |
Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Topics: Animals; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Dinoprostone; Embryo Implantation; Endometrium; Female; Hydroxyprostaglandin Dehydrogenases; Luteal Phase; Luteolytic Agents; Macaca mulatta; Male; Mifepristone; Misoprostol; Oxytocics; Prostaglandin-Endoperoxide Synthases; Prostaglandins | 1998 |
Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA.
Topics: Cycloheximide; Cyclooxygenase 2; Dactinomycin; Dexamethasone; Dinoprostone; Enzyme Induction; Hormone Antagonists; Humans; Interleukin-1; Isoenzymes; Kinetics; Lung; Lung Neoplasms; Membrane Proteins; Mifepristone; Prostaglandin-Endoperoxide Synthases; Repetitive Sequences, Nucleic Acid; RNA Processing, Post-Transcriptional; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor.
Topics: Cells, Cultured; Chorion; Decidua; Dexamethasone; Dihydrotestosterone; Dinoprostone; Female; Humans; Hydrocortisone; Hydroxyprostaglandin Dehydrogenases; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Progesterone; RNA, Messenger; Steroids; Trophoblasts | 1999 |
Cervical ripening after treatment with prostaglandin E2 or antiprogestin (RU486). Possible mechanisms in relation to gonadal steroids.
Topics: Adult; Biopsy; Cervical Ripening; Cervix Uteri; Collagen; Dinoprostone; Estradiol; Female; Gene Expression Regulation; Humans; Immunoenzyme Techniques; Insulin-Like Growth Factor I; Mifepristone; Pilot Projects; Progesterone; Receptors, Estrogen; Receptors, Progesterone; RNA Probes; RNA, Messenger | 1999 |
Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenocorticotropic Hormone; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Hydrocortisone; In Vitro Techniques; Isoenzymes; Labor, Induced; Meloxicam; Mifepristone; Pituitary-Adrenal System; Pregnancy; Prostaglandin-Endoperoxide Synthases; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Uterine Contraction | 2000 |
The expression of glutaredoxin is increased in the human cervix in term pregnancy and immediately post-partum, particularly after prostaglandin-induced delivery.
Topics: Abortifacient Agents, Steroidal; Adult; Cervix Uteri; Delivery, Obstetric; Dinoprostone; Female; Gene Expression; Glutaredoxins; Humans; Labor, Induced; Labor, Obstetric; Middle Aged; Mifepristone; Oxidoreductases; Pregnancy; Protein Biosynthesis; Proteins; RNA, Messenger | 2000 |
Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Benzimidazoles; Bucladesine; Calcimycin; Cell Differentiation; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dinoprostone; Drug Synergism; Enzyme Induction; Estradiol; Gene Expression Regulation, Neoplastic; Genes, Reporter; Glioma; Hybrid Cells; Hydrocortisone; Ionophores; Isoenzymes; Luciferases; Membrane Proteins; Mice; Mifepristone; Neoplasm Proteins; Nerve Tissue Proteins; Neuroblastoma; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Protein Synthesis Inhibitors; Receptors, Glucocorticoid; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transfection; Tretinoin; Tumor Cells, Cultured | 2001 |
Effects of indomethacin, luteinizing hormone (LH), prostaglandin E2 (PGE2), trilostane, mifepristone, ethamoxytriphetol (MER-25) on secretion of prostaglandin E (PGE), prostaglandin F2alpha (PGF2alpha) and progesterone by ovine corpora lutea of pregnancy
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Cyclooxygenase Inhibitors; Dihydrotestosterone; Dinoprost; Dinoprostone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrus; Ethamoxytriphetol; Female; Hormone Antagonists; In Vitro Techniques; Indomethacin; Luteinizing Hormone; Mifepristone; Pregnancy; Progesterone; Prostaglandins E; Sheep | 2001 |
Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Cells, Cultured; Chorion; Cortisone; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Enzyme Induction; Female; Glucocorticoids; Hormone Antagonists; Humans; Hydroxysteroid Dehydrogenases; Isoenzymes; Membrane Proteins; Mifepristone; Pregnancy; Prostaglandin-Endoperoxide Synthases; Receptors, Glucocorticoid; RNA, Messenger; Trophoblasts | 2002 |
Glucocorticoid involvement in suppression of NK activity following surgery in rats.
Topics: Alprostadil; Animals; Cimetidine; Corticosterone; Cytotoxicity, Immunologic; Dinoprostone; Glucocorticoids; Immune Sera; Injections, Subcutaneous; Killer Cells, Natural; Kinetics; Laparotomy; Male; Mifepristone; Postoperative Period; Rats; Rats, Inbred F344; Suppressor Factors, Immunologic; Tumor Cells, Cultured | 2003 |
Effects of prostaglandins E2 and F2alpha (PGE2; PGF2alpha), trilostane, mifepristone, palmitic acid (PA), indomethacin (INDO), ethamoxytriphetol (MER-25), PGE2 + PA, or PGF2alpha + PA on PGE2, PGF2alpha, and progesterone secretion by bovine corpora lutea
Topics: Abortifacient Agents, Steroidal; Animals; Cattle; Corpus Luteum; Dihydrotestosterone; Dinoprost; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Estrogen Antagonists; Ethamoxytriphetol; Female; In Vitro Techniques; Indomethacin; Mifepristone; Oxytocics; Palmitic Acid; Pregnancy; Progesterone; Tocolytic Agents | 2002 |
Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids.
Topics: Animals; Avoidance Learning; Behavior, Animal; Conditioning, Psychological; Corticosterone; Dinoprostone; Drug Interactions; Electroshock; Fear; Hormone Antagonists; Injections, Intraventricular; Interleukin-1; Interleukin-10; Male; Mifepristone; Rats; Rats, Wistar; Reaction Time; Time Factors | 2003 |
The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2.
Topics: Animals; Camphanes; Corticosterone; Dinoprostone; Dronabinol; Female; Hormone Antagonists; Immunosuppression Therapy; Interferon-gamma; Interleukin-12; Legionella pneumophila; Legionnaires' Disease; Mice; Mice, Inbred BALB C; Mifepristone; Piperidines; Pyrazoles; Radioimmunoassay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Th1 Cells | 2004 |
Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
Topics: Abortifacient Agents; Abortion, Induced; Dinoprostone; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Treatment Outcome | 2004 |
[Obstetrical prognosis of labour induction with mifepristone after 41 weeks of gestation].
Topics: Adult; Cesarean Section; Dinoprostone; Female; Gestational Age; Humans; Labor, Induced; Mifepristone; Pregnancy; Prognosis; Retrospective Studies | 2004 |
[Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy | 2004 |
Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release.
Topics: Arachidonic Acid; Binding, Competitive; Budesonide; Cell Line, Tumor; Cell Nucleus; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Inhibitory Concentration 50; Interleukin-1; Luciferases; Mifepristone; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Radioligand Assay; Receptors, Glucocorticoid; Response Elements; Transcription, Genetic | 2004 |
Delay of preterm birth in sheep by THG113.31, a prostaglandin F2alpha receptor antagonist.
Topics: Animals; Delivery, Obstetric; Dinoprost; Dinoprostone; Electromyography; Female; Fetal Blood; Hydrocortisone; In Vitro Techniques; Mifepristone; Myometrium; Peptides; Pregnancy; Pregnancy, Animal; Premature Birth; Receptors, Progesterone; Receptors, Prostaglandin; Sheep; Time Factors; Tocolytic Agents; Uterine Contraction; Uterus | 2005 |
Abortion procedures in a tertiary care institution in India.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Dinoprostone; Female; Humans; India; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Retrospective Studies | 2005 |
Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Weight; Corticosterone; Dinoprostone; Dopamine; Drug Interactions; Eicosapentaenoic Acid; Homovanillic Acid; Hormone Antagonists; Interleukin-1beta; Male; Mifepristone; Nucleus Accumbens; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2007 |
Steroid effects on intracellular degradation of insulin and crinophagy in isolated pancreatic islets.
Topics: Animals; Cell Separation; Corticosterone; Cyclooxygenase Inhibitors; Dinoprostone; Glucose; Heterocyclic Compounds, 2-Ring; Indomethacin; Insulin; Islets of Langerhans; Lysosomes; Male; Mice; Mifepristone; Progesterone; Quinolines; Receptors, Cell Surface; Secretory Vesicles; Steroids | 2007 |
Mifepristone attenuates human chorionic gonadotropin-induced extracellular signal-regulated kinase 1/2 phosphorylation, cyclooxygenase-2, and prostaglandin E2 production in human granulosa luteal cells.
Topics: Adult; Cells, Cultured; Chorionic Gonadotropin; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Female; Flavonoids; Hormone Antagonists; Humans; JNK Mitogen-Activated Protein Kinases; Luteal Cells; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Messenger | 2008 |
Gestagen treatment enhances the tocolytic effect of salmeterol in hormone-induced preterm labor in the rat in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Dinoprostone; Female; Mifepristone; Obstetric Labor, Premature; Pregnancy; Progestins; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate; Tocolysis | 2008 |
Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain.
Topics: Adrenalectomy; Analysis of Variance; Animals; Behavior, Animal; Corticosterone; Dinoprostone; Disease Models, Animal; Epinephrine; Hormone Antagonists; Hyperalgesia; Male; Mifepristone; Muscle, Skeletal; Neurons, Afferent; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Signal Transduction; Skin; Sound; Stress, Physiological; Time Factors | 2008 |
Hormonal regulation of prostaglandin E2 receptors: localization and expression in rat cervical tissue.
Topics: Animals; Cervical Ripening; Cervix Uteri; Dinoprostone; Epithelium; Female; Gene Expression; Hormone Antagonists; Immunohistochemistry; Mifepristone; Muscle, Smooth; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Uterine Contraction | 2010 |
[Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dinoprostone; Female; Fetal Diseases; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2009 |
Induction of progesterone receptor A form attenuates the induction of cytosolic phospholipase A2alpha expression by cortisol in human amnion fibroblasts.
Topics: Amnion; Cells, Cultured; Cyclooxygenase Inhibitors; Dihydrotestosterone; Dinoprostone; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Gene Knockdown Techniques; Genes, Reporter; Group IV Phospholipases A2; Hormone Antagonists; Humans; Hydrocortisone; Indomethacin; Ligands; Mifepristone; Progesterone; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; RNA, Small Interfering | 2010 |
Anti-inflammatory effect of bee venom on antigen-induced arthritis in rabbits: influence of endogenous glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Antigens; Arthritis, Experimental; Bee Venoms; Dinoprostone; Glucocorticoids; Leukocyte Count; Metyrapone; Mifepristone; Rabbits | 2010 |
Effects of progesterone on motility and prostaglandin levels in the distal guinea pig colon.
Topics: Acetylcholine; Animals; Antibodies; Colon; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Ethylmaleimide; Gastrointestinal Motility; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Guinea Pigs; In Vitro Techniques; Male; Mifepristone; Muscle Contraction; Muscle, Smooth; Myocytes, Smooth Muscle; Pertussis Toxin; Progesterone; Prostaglandins; Receptors, Prostaglandin; Vasoactive Intestinal Peptide | 2009 |
Anti-ovulatory effects of RU486 and trilostane involve impaired cyclooxygenase-2 expression and mitotic activity of follicular granulosa cells in rats.
Topics: Animals; Chorionic Gonadotropin; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Female; Granulosa Cells; Humans; Mifepristone; Mitosis; Ovarian Follicle; Ovulation; Progesterone; Rats; Rats, Wistar | 2011 |
Effect of mifepristone on COX-2 both in eutopic and ectopic endometrium in mouse endometriotic model.
Topics: Animals; Cyclooxygenase 2; Dinoprostone; Drug Evaluation, Preclinical; Endometriosis; Endometrium; Female; Fluorescence; Menstruation-Inducing Agents; Mice; Mice, Inbred C57BL; Mifepristone; RNA, Messenger | 2012 |
Prednisone inhibits the IL-1β-induced expression of COX-2 in HEI-OC1 murine auditory cells through the inhibition of ERK-1/2, JNK-1 and AP-1 activity.
Topics: Animals; Blotting, Western; Cell Line; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Enzymologic; Glucocorticoids; Hair Cells, Auditory; Hormone Antagonists; Interleukin-1beta; Mice; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Prednisone; Promoter Regions, Genetic; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factor AP-1 | 2014 |
FOS, a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory Prostaglandins in the Human Ovary.
Topics: Adult; Benzophenones; Cells, Cultured; Chorionic Gonadotropin; Dinoprostone; Epidermal Growth Factor; Female; Humans; Isoxazoles; Mifepristone; Ovarian Follicle; Ovulation; Primary Cell Culture; Progesterone; Proto-Oncogene Proteins c-fos; Quinazolines; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; Tyrphostins; Up-Regulation | 2018 |